Fucus vesiculosus polysaccharide alleviates type 2 diabetes in rats via remodeling gut microbiota and regulating glycolipid metabolism-related gene expression
Copyright © 2023 Elsevier B.V. All rights reserved..
The antidiabetic activity and underlying mechanisms of Fucus vesiculosus polysaccharide (FVP) were studied in type 2 diabetic rats. Our results exhibited that FVP intervention reversed body weight loss, alleviated hyperglycemia and insulin resistance in diabetic rats. FVP also had the potential to ameliorate dyslipidemia, liver and kidney dysfunction, decrease oxidative stress, promote glycogen synthesis, and boost short-chain fatty acid production and total bile acid excretion. 16S rRNA gene sequencing analysis suggested that FVP interfered with the gut microbiota in a beneficial manner. Moreover, RT-qPCR results demonstrated that the antidiabetic activity of FVP in connection with the acceleration of blood glucose absorption and glycogen synthesis, the inhibition of gluconeogenesis, and the regulation of lipid metabolism in the liver. These findings suggested that FVP had antidiabetic effects on high-fat diet and STZ-induced diabetic rats and could be a potential resource for treating type 2 diabetes mellitus.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:248 |
---|---|
Enthalten in: |
International journal of biological macromolecules - 248(2023) vom: 01. Sept., Seite 126504 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Zheng, Qianwen [VerfasserIn] |
---|
Links: |
---|
Themen: |
9005-79-2 |
---|
Anmerkungen: |
Date Completed 22.09.2023 Date Revised 09.01.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.ijbiomac.2023.126504 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM36123936X |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM36123936X | ||
003 | DE-627 | ||
005 | 20240114232942.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.ijbiomac.2023.126504 |2 doi | |
028 | 5 | 2 | |a pubmed24n1253.xml |
035 | |a (DE-627)NLM36123936X | ||
035 | |a (NLM)37625739 | ||
035 | |a (PII)S0141-8130(23)03400-1 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Zheng, Qianwen |e verfasserin |4 aut | |
245 | 1 | 0 | |a Fucus vesiculosus polysaccharide alleviates type 2 diabetes in rats via remodeling gut microbiota and regulating glycolipid metabolism-related gene expression |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 22.09.2023 | ||
500 | |a Date Revised 09.01.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2023 Elsevier B.V. All rights reserved. | ||
520 | |a The antidiabetic activity and underlying mechanisms of Fucus vesiculosus polysaccharide (FVP) were studied in type 2 diabetic rats. Our results exhibited that FVP intervention reversed body weight loss, alleviated hyperglycemia and insulin resistance in diabetic rats. FVP also had the potential to ameliorate dyslipidemia, liver and kidney dysfunction, decrease oxidative stress, promote glycogen synthesis, and boost short-chain fatty acid production and total bile acid excretion. 16S rRNA gene sequencing analysis suggested that FVP interfered with the gut microbiota in a beneficial manner. Moreover, RT-qPCR results demonstrated that the antidiabetic activity of FVP in connection with the acceleration of blood glucose absorption and glycogen synthesis, the inhibition of gluconeogenesis, and the regulation of lipid metabolism in the liver. These findings suggested that FVP had antidiabetic effects on high-fat diet and STZ-induced diabetic rats and could be a potential resource for treating type 2 diabetes mellitus | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Fucus vesiculosus polysaccharide | |
650 | 4 | |a Gut flora | |
650 | 4 | |a Hypoglycemic activity | |
650 | 4 | |a Possible mechanisms | |
650 | 7 | |a RNA, Ribosomal, 16S |2 NLM | |
650 | 7 | |a Hypoglycemic Agents |2 NLM | |
650 | 7 | |a Polysaccharides |2 NLM | |
650 | 7 | |a Glycolipids |2 NLM | |
650 | 7 | |a Glycogen |2 NLM | |
650 | 7 | |a 9005-79-2 |2 NLM | |
700 | 1 | |a Zheng, Yang |e verfasserin |4 aut | |
700 | 1 | |a Jia, Rui-Bo |e verfasserin |4 aut | |
700 | 1 | |a Luo, Donghui |e verfasserin |4 aut | |
700 | 1 | |a Chen, Chong |e verfasserin |4 aut | |
700 | 1 | |a Zhao, Mouming |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t International journal of biological macromolecules |d 1992 |g 248(2023) vom: 01. Sept., Seite 126504 |w (DE-627)NLM012627356 |x 1879-0003 |7 nnns |
773 | 1 | 8 | |g volume:248 |g year:2023 |g day:01 |g month:09 |g pages:126504 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ijbiomac.2023.126504 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 248 |j 2023 |b 01 |c 09 |h 126504 |